What are the Uses of PEG Derivatives & Polyethylene Glycols (PEGs)
Release date：2019/9/11 17:02:40
What are Polyethylene glycols (PEGs)?
Polyethylene glycols (PEGs) are polymers or hydrophilic oligomers generated from ethylene oxide, consisting of -( O-CH2-CH2)-repeating units. PEGs are produced in a wide range of molecular weights, referred to as "monodispersed" with the defined PEG molecular weight and chain size, or "polydispersed" polymers with the help of Gaussian distribution of molecular weights and chain lengths (Learn more the difference between monodispersed and polydispersed polymers). The ability to assign various reactive functional groups to the terminal sites of PEG polymers has extended their benefits. Homo and heterobifunctional PEG derivatives are suitable as crosslinking agents or spacers within chemical organizations, where mono-functional PEGs protect bridging responses affecting the PEGylation of different compounds with bifunctional PEGs.
The PEGylation method, covalent grafting of polyethylene glycol derivative (PEG derivative) on molecules, enhances water biocompatibility and solubility, specifically used for drug development. PEGylated-based products require an enormous characterization with analytical and critical methods to endure regulatory compliance for the application of medicine. Bifunctional PEG derivatives are used continually in the PEGylation of proteins, peptides, small molecules such as mannose, folate, oligonucleotides, prodrugs, nanoparticles, cells, surfaces and particles of the disease. Multi-arm PEG derivatives operate in hydrogel formation for regulated therapy release in medical devices, regenerative medicine, and multiple applications involving wound healing and cell culture. Significant developments in research & development for innovative applications for PEGs were made by the scientific community in 2014.
Then, what is polyethylene glycol used for?
Polyethylene Glycols Applications for the Targeted Diagnostics and Cancer Drug Delivery
R&D efforts on innovative applications of PEG derivatives focus on drug delivery & targeted diagnostics through direct therapeutic PEGylation or PEG containing vehicles such as liposomes, micelles, nanoparticles and dendrimers. Significant parameters affecting PEGylated drug bioactivity include PEGylation site, PEGylation chain length, temperature particular for PEGylation reaction and linker chemistry. For example, heat treatment was displayed to enhance the bioactivity of C-terminally PEGylated staphylokinases, where the amyl linker for around 20 kDa PEG developed the bioactivity of staphylokinases. Choosing the organic solvent for the hydrophobic proteins has the ability to lower the cost of response times and reagents where parameters are important for industrial scale PEGylation procedures. The advanced water solubility, regulated release, enhanced stability, prolonged drug and improved pharmacodynamics / pharmacokinetic profile are among the improvements made by PEGylation for therapeutics.
Multi-arm PEG links the drug molecules in the growth of PEGylation of small molecule medicines, sustaining enormous drug load and improving drug release function. As an example, iRGD peptide's increasing molecular weight through prolonged PEGylation into macromolecular extravasation and full drug penetration into tumors and improved iRGD's pharmacokinetic profile to the unmodified peptide.
The best substitutes for PEGylation of drugs are PEG-containing vehicles for drug delivery such as dendrimers, liposomes, micelles or nanoparticles. Liposomes experience inert extravasation in tumor tissues where the ligands are unprotected by the controlled exogenous administration of reduced l-cysteine. RGD therefore identifies integrins, expressed on malignant tumors, searching deeply in vascular tumor spheroids, and internalization in synergistic effect with TAT. The insertion area in the alkyl grafts of reducible polymers and the oleic acid layer on the surface of the nanoparticles stored the hydrophobic drug for drug delivery, while PEG chains increased the dispersion of nanoparticles in the aqueous environment.
Polyethylene Glycol Applications in Tissue Regeneration and Wound Healing
The use as adhesives for wound closure, wound healing, controlled release matrices for therapy, regenerative medicine tools and part of medical devices are among the main uses of PEG hydrogels. Swelling behaviour, storage modules of bioadhesive hydrogel and degradation profiles have been familiar by altering the degree of alginate oxidation. In comparing the commercially available fibrin glue, the adhesion level on the porcine skin model has been improved. The effect of pH on intermolecular cross-linking and connection to biological substrates enabled optimal buffering pH to be recognized for adhesive formulation. When testing the adhesive for pericardium tissue, the formulation pH of around 7.5 offered the perfect model of mechanical properties, curing rate and the Catechol interfacial binding capacity consisting of the PEG hydrogel with dopamine.
The molecular weight of the polyethylene glycol chain as part of composite hydrogels does not have a significant effect on cell division and the production of glycosaminoglycan. Similarly, a' tissue-engineered periosteum' is generated for regenerative medicine purposes by using hydrolytically degradable PEG hydrogels to localize and transplant mesenchymal stem cells for surface allograft. The method developed vascularization of the healing graft, biomechanical strength and endochondral bone formation to compare the allografts not treated. The endochondral ossification procedure for comparing untreated allografts, requiring future hydrogel supplementation with additives to speed up the ossification procedure for the treatment of crucial bone defects in size.
Polyethylene Glycol Applications in Tissue Models and Cell Culture
PEG-copolymer and PEG hydrogels are the alternatives used as cell culture scaffolds, for regulated therapeutic release and other applications not restricted to tissue engineering. PEG hydrogels with the range and elasticity of the physiologically associated matrix diffusion, invented in transwell inserts used by the valvular endothelial and interstitial cell society. Increased PEG hydrogel matrice cells allowed the suitable investigations connected with the development and initiation of the valve stenosis.
Bio-synthetic tissue scaffolding consisting of the interpenetrating network of gelatin methacrylamide polymerized in the polyethylene glycol framework for the endothelial cells culture. The tissue model showed the enormous cytoplasmic spread and cell adhesion, with ongoing viability and proliferation for adherent and encapsulated cells.
The system's hydrogel based on the polyethylene glycol macromere allowed the superficial inclusion of bioactive peptides for improved cell-matrix interactions. The 3D hydrogel system regulates NCTP expression in summarized cell lines of HepG2 and Huh7 and hepatocyte-like polarity, deprived of genetic modification and requirement for chemical additives and growth factors.
In drug delivery, cancer diagnosis, wound healing, tissue scaffolding models, cell culture and tissue regeneration, various uses of polyethylene glycol and PEG hydrogels are used. Other polyethylene glycol applications include PEGylation of large and small molecules such as proteins, peptides, mannose, folate, cell PEGylation, oligonucleotides, virus & nanoparticles, and surface alteration.
Biochempeg offers a broad portfolio of PEG derivatives and PEG linkers with molecular weights up to 20 kDa for efficient PEGylations. Numerous homobifunctionalized, heterobifunctionalized, and mono-methoxy endcapped monofunctionalized linear PEG's are available in high quality. We provide polyethylene glycols activated for the most widely used conjugations to primary amines or thiols. The introduction of different protecting groups leads to extremely useful macromolecular cross-linking agents and spacers.
Application of Polyethylene Glycol (PEG) In The Field Of Medical Devices
List of PEG Derivatives Application